Antiphospholipid syndrome echocardiography or ultrasound: Difference between revisions
No edit summary |
Feham Tariq (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Antiphospholipid syndrome}} | {{Antiphospholipid syndrome}} | ||
{{CMG}} | {{CMG}}{{AE}}{{FT}} | ||
==Overview== | ==Overview== | ||
==Antiphospholipid syndrome echocardiography or ultrasound== | |||
==References== | ==References== | ||
Revision as of 18:50, 11 April 2018
|
Antiphospholipid syndrome Microchapters |
|
Differentiating Antiphospholipid syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Antiphospholipid syndrome echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Antiphospholipid syndrome echocardiography or ultrasound |
|
FDA on Antiphospholipid syndrome echocardiography or ultrasound |
|
CDC on Antiphospholipid syndrome echocardiography or ultrasound |
|
Antiphospholipid syndrome echocardiography or ultrasound in the news |
|
Blogs on Antiphospholipid syndrome echocardiography or ultrasound |
|
Risk calculators and risk factors for Antiphospholipid syndrome echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]